NSC
57
3
KLAC
72
2
ZTS
29
6
GLW
90
6
JBHT
76
6
EMN
58
3
AAPL
50
2
CNP
62
2
PNC
61
5
LEG
62
-2
VZ
47
2
MLM
63
5
AEE
74
3
TXN
48
2
PEP
74
12
TSN
43
-4
V
40
4
EA
38
2
MCHP
54
-8
RL
70
5
NSC
57
3
KLAC
72
2
ZTS
29
6
GLW
90
6
JBHT
76
6
EMN
58
3
AAPL
50
2
CNP
62
2
PNC
61
5
LEG
62
-2
VZ
47
2
MLM
63
5
AEE
74
3
TXN
48
2
PEP
74
12
TSN
43
-4
V
40
4
EA
38
2
MCHP
54
-8
RL
70
5
Financhill
Back

Microsoft Corp. Vs. Spyre Therapeutics, Inc. Industry Stock Comparison

Sell
39

MSFT
Microsoft Corp.

Last Price:
$397.27
Seasonality Move:
7.26%
Buy
72

SYRE
Spyre Therapeutics, Inc.

Last Price:
$43.26
Seasonality Move:
-1.59%
Sell
39
Microsoft Corp. (MSFT) is a Sell

Is Microsoft Corp. a Buy, Sell or Hold?

  • The current Microsoft Corp. [MSFT] share price is $397.23. The Score for MSFT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • MSFT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Spyre Therapeutics, Inc. (SYRE) is a Buy

Is Spyre Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Spyre Therapeutics, Inc. [SYRE] share price is $43.21. The Score for SYRE is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • SYRE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MSFT Stock Price Chart

What is Microsoft Corp.'s stock price today?

  • The Microsoft Corp. share price today is $397.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MSFT is experiencing slight selling pressure.

SYRE Stock Price Chart

What is Spyre Therapeutics, Inc.'s stock price today?

  • The Spyre Therapeutics, Inc. share price today is $43.21
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYRE is experiencing buying pressure, which is a positive indicator for future bullish movement.

MSFT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -17.77 Sell
Relative Strength Index (14 RSI): 32.03 Sell
Chaikin Money Flow: -5600000 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (399.24 - 456.66) Sell
Bollinger Bands (100): (443.05 - 518.45) Sell

SYRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.48 Buy
Relative Strength Index (14 RSI): 76.95 Buy
Chaikin Money Flow: 2001107 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.94 - 36.64) Buy
Bollinger Bands (100): (22.31 - 34.55) Buy

MSFT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 401.62 Sell
20-day SMA: 421.62 Sell
50-day SMA: 454.13 Sell
200-day SMA: 486.88 Sell
8-day EMA: 402.14 Sell
20-day EMA: 417.86 Sell
50-day EMA: 445.33 Sell
200-day EMA: 468.51 Sell

SYRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.57 Buy
20-day SMA: 34.45 Buy
50-day SMA: 33.41 Buy
200-day SMA: 22.2 Buy
8-day EMA: 21.06 Buy
20-day EMA: 10.23 Buy
50-day EMA: 4.44 Buy
200-day EMA: 1.16 Buy

Microsoft Corp. Earnings Growth & MSFT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.77 per share, a decrease next quarter of $0.03 per share, an increase this year of $3.31 per share, and an increase next year of $2.12 per share.

Spyre Therapeutics, Inc. Earnings Growth & SYRE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.46 per share, a decrease this year of $0.85 per share, and an increase next year of $0.08 per share.

Microsoft Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Spyre Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):